DN
Dianthus Therapeutics Inc.
DNTH · Dianthus Therapeutics Inc. · Healthcare
Up next day
7/12
58%
Fell despite growth
1/12
Good earnings ignored
Avg earnings move
±4.8%
typical swing on earnings
Price when beating
+2.6%
avg over 5 beats
Biggest single move
+14.3%
'23.12 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Good results usually push the stock up
Up the next day 4 of 5 beats (80%)
Reaction is erratic and hard to predict
Avg +2.6% on a beat, +0.7% on a miss
Big earnings-day moves tend to fade within days
Reversed the day-one move · 67% of last 12
vs Healthcare sector avg (153 peers)
This
+1.5%
Sector
+0.4%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
This stock mostly moves with the reported earnings number
Moved opposite to results 4 of last 12 times (33%)
1xBeat but fell
Even a beat sells off if guidance disappoints
3xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Nov 5After close
'26.9 expectedEst. EPS $-1.02
Quarter ended 6/2026
Reported 2026-08-04
Next-day move
+1.9%
After 5 days -1.7%
vs Consensus$-0.91→$-0.90+1.0% beat
EPS
$-0.90
YoY -2%
Revenue
—
Next-Q guidance
—
N/A
Price around earnings
Rose despite missvs market +2.1%p+24% run-up before
Earnings trend · last 12 quarters
EPS$-0.90YoY -2%
'23.9'26.6
Revenue—
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
6x55%
Met expectations
good · up ↑
0x
Disappointment
weak · down ↓
3x27%
Good earnings ignored
good · down ↓
2x18%
← ← Weak earningsStrong earnings → →
Price rose even on weak earnings — bad news priced in / buy-the-dip · 6 of 11q (55%)
Community · DNTH
What do you think of this stock's earnings pattern?
···